These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31857406)

  • 1. Do dolphins get Alzheimer's disease?
    Di Guardo G
    Vet Rec; 2019 Dec; 185(24):762. PubMed ID: 31857406
    [No Abstract]   [Full Text] [Related]  

  • 2. Protein aggregation in Alzheimer's disease: Aβ and τ and their potential roles in the pathogenesis of AD.
    Thal DR; Fändrich M
    Acta Neuropathol; 2015 Feb; 129(2):163-5. PubMed ID: 25600324
    [No Abstract]   [Full Text] [Related]  

  • 3. Does the difference between PART and Alzheimer's disease lie in the age-related changes in cerebral arteries that trigger the accumulation of Aβ and propagation of tau?
    Weller RO; Hawkes CA; Carare RO; Hardy J
    Acta Neuropathol; 2015 May; 129(5):763-6. PubMed ID: 25814152
    [No Abstract]   [Full Text] [Related]  

  • 4. Neurofibrillary tangles and beta-amyloid deposits in Alzheimer's disease.
    Goedert M; Sisodia SS; Price DL
    Curr Opin Neurobiol; 1991 Oct; 1(3):441-7. PubMed ID: 1821689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On keys and correlations in Alzheimer's disease.
    Potter H
    Neurobiol Aging; 1996; 17(6):943-4; discussion 945-7. PubMed ID: 9363810
    [No Abstract]   [Full Text] [Related]  

  • 6. In vivo Patterns of Tau Pathology, Amyloid-β Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer's Disease.
    Dronse J; Fliessbach K; Bischof GN; von Reutern B; Faber J; Hammes J; Kuhnert G; Neumaier B; Onur OA; Kukolja J; van Eimeren T; Jessen F; Fink GR; Klockgether T; Drzezga A
    J Alzheimers Dis; 2017; 55(2):465-471. PubMed ID: 27802224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of animal models for therapy of Alzheimer's disease].
    Shoji M
    Nihon Ronen Igakkai Zasshi; 2003 Jan; 40(1):27-9. PubMed ID: 12649842
    [No Abstract]   [Full Text] [Related]  

  • 8. Understanding the cause of sporadic Alzheimer's disease.
    Zetterberg H; Mattsson N
    Expert Rev Neurother; 2014 Jun; 14(6):621-30. PubMed ID: 24852227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid-β may be released from non-junctional varicosities of axons generated from abnormal tau-containing brainstem nuclei in sporadic Alzheimer's disease: a hypothesis.
    Braak H; Del Tredici K
    Acta Neuropathol; 2013 Aug; 126(2):303-6. PubMed ID: 23824268
    [No Abstract]   [Full Text] [Related]  

  • 10. Alzheimer's disease-related lesions.
    Alafuzoff I
    J Alzheimers Dis; 2013; 33 Suppl 1():S173-9. PubMed ID: 22695621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma tau/amyloid-β1-42 ratio predicts brain tau deposition and neurodegeneration in Alzheimer's disease.
    Park JC; Han SH; Yi D; Byun MS; Lee JH; Jang S; Ko K; Jeon SY; Lee YS; Kim YK; Lee DY; Mook-Jung I
    Brain; 2019 Mar; 142(3):771-786. PubMed ID: 30668647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Power tools for Alzheimer's disease - an electrochemical preamp for Aβ.
    Zetterberg H; Hammarström P
    J Neurochem; 2012 Jul; 122(2):231-2. PubMed ID: 22409410
    [No Abstract]   [Full Text] [Related]  

  • 13. Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models.
    Götz J; Schild A; Hoerndli F; Pennanen L
    Int J Dev Neurosci; 2004 Nov; 22(7):453-65. PubMed ID: 15465275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The spectrum series: grappling with the overlap between Alzheimer's and Parkinson's diseases. 9th International Conference on Alzheimer's and Parkinson's Diseases, 11-15 March 2009, Prague,Czech Republic.
    Strobel G
    J Alzheimers Dis; 2009; 18(3):625-40. PubMed ID: 19749400
    [No Abstract]   [Full Text] [Related]  

  • 15. The search for improved animal models of Alzheimer's disease and novel strategies for therapeutic intervention.
    Li C; Briner A; Götz J
    Future Med Chem; 2019 Aug; 11(15):1853-1857. PubMed ID: 31517531
    [No Abstract]   [Full Text] [Related]  

  • 16. Yeast Model of Amyloid-β and Tau Aggregation in Alzheimer's Disease.
    Moosavi B; Mousavi B; Macreadie IG
    J Alzheimers Dis; 2015; 47(1):9-16. PubMed ID: 26402750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing the Amyloid Hypothesis with a Humanized AD Mouse Model.
    Cahill MK; Huang EJ
    Neuron; 2017 Mar; 93(5):987-989. PubMed ID: 28279360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease: relationship between muscarinic cholinergic receptors, beta-amyloid and tau proteins.
    Pavía J; de Ceballos ML; Sanchez de la Cuesta F
    Fundam Clin Pharmacol; 1998; 12(5):473-81. PubMed ID: 9794144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of Disease-modifying Therapy for Alzheimer's Disease].
    Akiyama H
    Brain Nerve; 2016 Apr; 68(4):463-72. PubMed ID: 27056864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.